Use Of Ulipristal Acetate For Treating Uterine Fibroids

Patent No. EP2684565 (titled "Use Of Ulipristal Acetate For Treating Uterine Fibroids") was filed by Laboratoire HRA Pharma on Jan 28, 2009. The application was issued on Oct 2, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
HOFFMANN EITLE	Jul 2, 2020	HOFFMANN EITLE
WITTKOPP	Jul 2, 2020	HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

May 10, 2022
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 10, 2022
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 10, 2022
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
May 4, 2022
Termination of the opposition proceedings with revocation of patent
Jan 31, 2022
Advice of delivery
Jan 26, 2022
Advice of delivery
Jan 25, 2022
Decision of the Opposition Division and instruction
Jan 25, 2022
Decision revoking the European patent
Jan 25, 2022
Decision revoking the European patent
Jan 25, 2022
Decision revoking the European patent
Jan 25, 2022
Grounds for the decision (Annex) - opposition
Jan 25, 2022
Means of redress
Jan 25, 2022
Transmittal of decision / summons - opposition
Jan 25, 2022
Transmittal of decision / summons - opposition
Jan 25, 2022
Transmittal of decision / summons - opposition
Dec 8, 2021
Notification concerning the date of oral proceedings
Dec 8, 2021
Notification concerning the date of oral proceedings
Dec 8, 2021
Notification concerning the date of oral proceedings
Nov 24, 2021
Brief communication - Opposition proceedings
Nov 24, 2021
Brief communication - Opposition proceedings
Nov 19, 2021
(Electronic) Receipt
Nov 19, 2021
Letter accompanying subsequently filed items
Nov 19, 2021
Withdrawal of a request for oral proceedings
Oct 28, 2021
Brief communication - Opposition proceedings
Oct 28, 2021
Brief communication - Opposition proceedings
Oct 25, 2021
(Electronic) Receipt
Oct 25, 2021
Letter accompanying subsequently filed items
Oct 25, 2021
Written submission in preparation to/during oral proceedings
Sep 27, 2021
Communication of amended entries concerning the representative
Jul 27, 2021
Notification concerning the date of oral proceedings
Jul 27, 2021
Notification concerning the date of oral proceedings
Jul 27, 2021
Notification concerning the date of oral proceedings
Mar 12, 2021
Advice of delivery
Mar 10, 2021
Advice of delivery
Mar 9, 2021
Annex to the communication - opposition
Mar 9, 2021
Information concerning oral proceedings
Mar 9, 2021
Summons to attend oral proceedings
Mar 9, 2021
Summons to attend oral proceedings
Mar 9, 2021
Summons to attend oral proceedings
Mar 9, 2021
Transmittal of decision / summons - opposition
Mar 9, 2021
Transmittal of decision / summons - opposition
Mar 9, 2021
Transmittal of decision / summons - opposition
Jul 14, 2020
Communication of a notice of opposition and request to file observations
Jul 14, 2020
Notice of further oppositions to opponent(s)
Jul 14, 2020
Notice of further oppositions to opponent(s)
Jul 9, 2020
Communication of a notice of opposition - first information to patent proprietor
Jul 2, 2020
(Electronic) Receipt
Jul 2, 2020
(Electronic) Receipt
Jul 2, 2020
Citation in opposition procedure
Jul 2, 2020
Citation in opposition procedure
Jul 2, 2020
Citation in opposition procedure
Jul 2, 2020
Citation in opposition procedure - 001
Jul 2, 2020
Citation in opposition procedure - 002
Jul 2, 2020
Citation in opposition procedure - 003
Jul 2, 2020
Citation in opposition procedure - 004
Jul 2, 2020
Citation in opposition procedure - 005
Jul 2, 2020
Citation in opposition procedure - 006
Jul 2, 2020
Citation in opposition procedure - 007
Jul 2, 2020
Citation in opposition procedure - 008
Jul 2, 2020
Citation in opposition procedure - 009
Jul 2, 2020
Citation in opposition procedure - 010
Jul 2, 2020
Citation in opposition procedure - 011
Jul 2, 2020
Citation in opposition procedure - 012
Jul 2, 2020
Citation in opposition procedure - 013
Jul 2, 2020
Citation in opposition procedure - 014
Jul 2, 2020
Citation in opposition procedure - 015
Jul 2, 2020
Citation in opposition procedure - 016
Jul 2, 2020
Consolidated list of cited opposition documents
Jul 2, 2020
Notice of opposition
Jul 2, 2020
Notice of opposition
Jul 2, 2020
Notice of opposition
Jul 2, 2020
Notice of opposition
Oct 14, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Sep 5, 2019
Decision to grant a European patent
Aug 28, 2019
Communication of the registration of a transfer or change of name and/or address
Aug 20, 2019
(Electronic) Receipt
Aug 20, 2019
(Electronic) Receipt
Aug 20, 2019
Filing of the translations of the claims
Aug 20, 2019
French translation of claims
Aug 20, 2019
German translation of the claims
Aug 20, 2019
Letter accompanying subsequently filed items
Aug 20, 2019
Letter accompanying subsequently filed items
Aug 20, 2019
Submission concerning change of applicant's address
Apr 17, 2019
Bibliographic data of the European patent application
Apr 17, 2019
Communication about intention to grant a European patent
Apr 17, 2019
Intention to grant (signatures)
Apr 17, 2019
Text intended for grant (clean copy)
Apr 17, 2019
Text intended for grant (version for approval)
Jan 11, 2019
Decision to allow further processing
Dec 20, 2018
(Electronic) Receipt
Dec 20, 2018
Letter accompanying subsequently filed items
Dec 20, 2018
Non-patent literature cited during the examination procedure
Dec 20, 2018
Non-patent literature cited during the examination procedure
Dec 20, 2018
Non-patent literature cited during the examination procedure
Dec 20, 2018
Request for further processing
Oct 30, 2018
Application deemed to be withdrawn (no reply to communication from the Examining Division)
Jul 26, 2018
Grant of extension of time limit (examination procedure)
Jul 16, 2018
(Electronic) Receipt
Jul 16, 2018
Letter accompanying subsequently filed items
Jul 16, 2018
Request for extension of time limit to communication from the Examining Division
May 28, 2018
Grant of extension of time limit (examination procedure)
May 22, 2018
(Electronic) Receipt
May 22, 2018
Letter accompanying subsequently filed items
May 22, 2018
Request for extension of time limit to communication from the Examining Division
Jan 24, 2018
Annex to the communication
Jan 24, 2018
Communication from the Examining Division
Jan 16, 2018
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Nov 15, 2017
Transmittal of third party observations to applicant
Nov 8, 2017
Citation filed by a third party
Nov 8, 2017
Citation filed by a third party
Nov 8, 2017
Citation filed by a third party
Nov 8, 2017
Observations by third parties
Oct 24, 2017
Bibliographic data of the European patent application
Oct 24, 2017
Communication about intention to grant a European patent
Oct 24, 2017
Intention to grant (signatures)
Oct 24, 2017
Text intended for grant (clean copy)
Oct 24, 2017
Text intended for grant (version for approval)
Dec 12, 2016
(Electronic) Receipt
Dec 12, 2016
Amended claims with annotations
Dec 12, 2016
Amended description with annotations
Dec 12, 2016
Claims
Dec 12, 2016
Description
Dec 12, 2016
Letter accompanying subsequently filed items
Dec 12, 2016
Reply to communication from the Examining Division
Jul 22, 2016
Grant of extension of time limit (examination procedure)
Jul 18, 2016
(Electronic) Receipt
Jul 18, 2016
Letter accompanying subsequently filed items
Jul 18, 2016
Request for extension of time limit to communication from the Examining Division
Jun 9, 2016
Annex to the communication
Jun 9, 2016
Communication from the Examining Division
Feb 4, 2016
(Electronic) Receipt
Feb 4, 2016
Amended claims with annotations
Feb 4, 2016
Claims
Feb 4, 2016
Letter accompanying subsequently filed items
Feb 4, 2016
Non-patent literature cited during the examination procedure
Feb 4, 2016
Reply to communication from the Examining Division
Dec 1, 2015
Grant of extension of time limit (examination procedure)
Nov 25, 2015
(Electronic) Receipt
Nov 25, 2015
Letter accompanying subsequently filed items
Nov 25, 2015
Request for extension of time limit to communication from the Examining Division
Aug 5, 2015
Annex to the communication
Aug 5, 2015
Communication from the Examining Division
Jul 30, 2015
Examination started
Jul 3, 2014
(Electronic) Receipt
Jul 3, 2014
Amended claims filed after receipt of (European) search report
Jul 3, 2014
Amended claims with annotations
Jul 3, 2014
Amendments received before examination
Jul 3, 2014
Letter accompanying subsequently filed items
Jan 20, 2014
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Dec 18, 2013
Notification of forthcoming publication
Dec 2, 2013
Communication to designated inventor
Dec 2, 2013
Communication to designated inventor
Dec 2, 2013
Communication to designated inventor
Dec 2, 2013
Communication to designated inventor
Nov 15, 2013
Communication regarding the transmission of the European search report
Nov 15, 2013
European search opinion
Nov 15, 2013
European search report
Nov 6, 2013
Search started
Oct 9, 2013
Abstract
Oct 9, 2013
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Oct 9, 2013
Claims
Oct 9, 2013
Description
Oct 9, 2013
Designation of inventor
Oct 9, 2013
Designation of inventor
Oct 9, 2013
Designation of inventor
Oct 9, 2013
Designation of inventor
Oct 9, 2013
Drawings
Oct 9, 2013
Request for grant of a European patent
Oct 14, 2009
Priority document (electronically transmitted)

EP2684565

LABORATOIRE HRA PHARMA

Application Number: EP13187859A
Filing Date: Jan 28, 2009
Status: Revoked; May 6, 2022
Publication Date: Oct 2, 2019
External Links: Slate, Register , Google Patents

IP Verse

Use Of Ulipristal Acetate For Treating Uterine Fibroids

Patent Summary

Patent Family

Patent Oppositions (2)

Dossier Documents

EP2684565